From the Journals

Certain Women May Face Higher Risk for Second Breast Cancer


 

SOURCE:

This study, led by Kristen D. Brantley, PhD, from Harvard T. H. Chan School of Public Health, Boston, was published online in JAMA Oncology.

LIMITATIONS:

A small number of second breast cancer events limited the authors’ ability to assess the effects of multiple risk factors together. Data on risk factors might be incomplete. About 9% of participants completed abbreviated questionnaires that did not include information on body mass index, alcohol, smoking, and family history. Frequencies of pathogenic variants besides BRCA1 and BRCA2 may be underestimated.

DISCLOSURES:

This study received no external funding. Four authors reported receiving grants or royalties outside this work. Other reported no competing interests.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Do Tumor-infiltrating Lymphocytes Predict Better Breast Cancer Outcomes?
MDedge ObGyn
FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
MDedge ObGyn
Less Than 50% of Accelerated Approvals Show Clinical Benefit
MDedge ObGyn
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant Immunotherapy
MDedge ObGyn
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
MDedge ObGyn
Do Real-World Data Support Omitting Sentinel Lymph Node Biopsy in Early Stage Breast Cancer?
MDedge ObGyn
No Routine Cancer Screening Option? New MCED Tests May Help
MDedge ObGyn
How Medicare Reimbursement Trends Could Affect Breast Surgeries
MDedge ObGyn
Is Axillary Surgery in Early Breast Cancer on Its Way Out?
MDedge ObGyn
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
MDedge ObGyn